Literatur
Balasubramaniam K, Grambsch PM, Wiesner RH, Lindor KD, Dickson ER. Diminished survival in asymptomatic primary biliary cirrhosis. Gastroenterology 1990;98:1567–71.
Berg PA, Klein R. Heterogeneity of antimitochondrial antibodies. Semin Liver Dis 1989;9:103–16.
Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996;335:1570–580.
Klein R, Klöppel G, Garbe W, Fintelmann V, Berg PA. Antimitochondrial antibody profiles determined at early stages of primary bilary cirrhosis differentiate between a benign and a progressive course of disease. A retrospective analysis of 76 patients over 6–18 years. J Hepatol 1991;2:21–7.
Lindor KD, Dickson ER, Baldus WP, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994;106:1284–90.
Poupon RE, Poupon R, Balkau B, and the UDCA-PBC study group: Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994;330:1342–7.
Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884–90.
Schönfeld J v, Breuer N, Zotz RB, Beste M, Goebell H. Serial quantitative liver function tests in patients with primary biliary cirrhosis: a prospective long term study. Digestion 1997;58:396–401.
Wiesner RH, Porayko MK, Dickson ER, et al. Selection and timing of liver transplantation in primary biliary cirrhosis and primary scierosing cholangitis. Hepatology 1992;16:1290–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
v. Schönfeld, J., Breuer, N. & Goebell, H. Primär biliäre Zirrhose: Diagnostik und Therapie. Med Klin 93, 627–628 (1998). https://doi.org/10.1007/BF03042679
Issue Date:
DOI: https://doi.org/10.1007/BF03042679